Explore Business Standard
Don’t miss the latest developments in business and finance.
The 'clinical' case of Ivermectin for Covid-19: To use or not to use
A debate has broken out over the safety and efficacy of the drug Ivermectin after Goa’s Health Minister Vishwajit Rane announced that all adults (18 and above) be given the medicine as prophylaxis to bring down mortality amid a surge in Covid cases. Scientists and doctors, including the World Health Organisation (WHO), have advised against the use of Ivermectin for Covid. What is Ivermectin and what is the Indian government's take over its use for treating Covid patients? Watch the video